Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: Bioorg Med Chem Lett. 2014 Dec 1;24(23):5439–5445. doi: 10.1016/j.bmcl.2014.10.027

Figure 1.

Figure 1

Structures of entry inhibitors developed by Bristol-Myers Squibb and the New York Blood Bank. The chemical structures were drawn with ChemAxon software (Budapest, Hungary).